StockData
Odyssey Therapeutics, Inc. logo

Odyssey Therapeutics, Inc. (ODTX) stock

ODTXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026
$19.14−0.96 (-4.78%)

Close on Nov 13, 2026Market cap $919.84MP/E –Yield –

Odyssey Therapeutics statistics

37 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings
–
Last ex-dividend date
No dividends
Fundamentals through
Sep 30, 2026
Share price as of
Nov 13, 2026

Valuation ratiosIndustry

Market Cap
$919.84M
$272.32M
Enterprise Value
$593.84M
$146.23M
PB Ratio
2.45
2.00
P/TBV Ratio
2.54
2.22

Share statisticsIndustry

Shares Change (QoQ)
0.10%
0.50%
Float
39M
49M
Shares Held by Insiders
19.7%
11.7%
Shares Held by Institutions
72.4%
56.4%

Short sellingIndustry

Short Interest
3M
–
Short Interest Change
2.01%
-0.80%
Short % of Float
8.67%
9.01%
Short % of Shares Outstanding
6.97%
6.30%
Days to Cover
15.43
5.15

Stock price statisticsIndustry

20-Day Moving Average
$19.53
–
50-Day Moving Average
$20.64
–
Average True Range (14)
$1.76
–
Price Change (1 Week)
-0.47%
-1.15%
Price Change (1 Month)
8.94%
-4.87%
Price Change (3 Months)
-8.25%
-21.0%
Price Change (6 Months)
8.63%
-20.6%
Average Volume (10 Days)
426,407
–
Average Volume (20 Days)
322,958
–
Average Volume (90 Days)
283,791
–
Relative Volume
1.14
0.70
Relative Strength Index (14)
46.8
43.4
Volatility (1 Year)
71.4%
80.1%

Financial positionIndustry

Current Ratio
12.94
3.30
Quick Ratio
12.49
2.39

Balance sheetIndustry

Net Cash (Debt)
$326.00M
$17.76M
Net Cash Per Share
$6.78
$0.80
Equity (Book Value)
$375.77M
$53.89M
Book Value Per Share
$7.82
$1.50
Tangible Book Value
$361.65M
$27.13M
Working Capital
$311.70M
$79.99M

Scores and fair valueIndustry

Altman Z-Score
7.43
0.23

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.

PeriodODTXS&P 500DifferenceODTX per yearS&P 500 per year
1 month+11.0%-3.0%+14.1 pts
3 months-7.6%-2.8%−4.8 pts

Short interest

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

3M ODTX shares were sold short on Oct 30, 2026, up 2.0% from the previous report, or 8.67% of the shares available to trade. At recent volumes it would take 15.4 days to buy them back. Over the last 20 sessions, 73.4% of the volume reported to FINRA was short selling.

Settlement dateShares shortChangeAvg. daily volumeDays to cover
Oct 30, 20263,347,791+2.0%216,97015.4
Oct 15, 20263,281,824+5.7%265,04712.4
Sep 30, 20263,105,465+40.6%551,2075.6
Sep 15, 20262,208,686-0.0%204,87610.8
Aug 31, 20262,208,908-1.8%172,37112.8
Aug 14, 20262,249,359-0.9%120,56018.7
Jul 31, 20262,270,930+13.9%234,6589.7
Jul 15, 20261,993,860+11.0%306,3206.5
Jun 30, 20261,796,735+33.7%487,8433.7
Jun 15, 20261,343,395+161.1%282,9804.8
May 29, 2026514,441+494.7%335,1361.5
May 15, 202686,503–426,6521.0

Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.

See a number that looks wrong?